Autopsy report · NCT00854581

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Investigator Decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 3 months after it had already started.
Ran for about 4 years before it stopped.
13 participants enrolled.
Results were posted on the registry 3 years 2 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 4
Sponsor: University of Miami
Sponsor type: University, hospital or other
Conditions: Lymphoma; Precancerous/Nonmalignant Condition
Interventions: PEG-interferon alfa-2b; Interferon alfa-2b; Valproic Acid; Zidovudine
Participants: 13
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.